Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG.
Saved in:
| Title: | Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG. |
|---|---|
| Authors: | Iyer S; Perlara PBC, 2625 Alcatraz Ave #435, Berkeley, CA 94705, USA., Sam FS; Perlara PBC, 2625 Alcatraz Ave #435, Berkeley, CA 94705, USA., DiPrimio N; Perlara PBC, 2625 Alcatraz Ave #435, Berkeley, CA 94705, USA., Preston G; Department of Clinical Genomics and Department of Laboratory Medicine, Mayo Clinic, Rochester, MN 55902, USA., Verheijen J; Department of Clinical Genomics and Department of Laboratory Medicine, Mayo Clinic, Rochester, MN 55902, USA., Murthy K; Perlara PBC, 2625 Alcatraz Ave #435, Berkeley, CA 94705, USA., Parton Z; Perlara PBC, 2625 Alcatraz Ave #435, Berkeley, CA 94705, USA., Tsang H; Perlara PBC, 2625 Alcatraz Ave #435, Berkeley, CA 94705, USA., Lao J; Perlara PBC, 2625 Alcatraz Ave #435, Berkeley, CA 94705, USA., Morava E; Department of Clinical Genomics and Department of Laboratory Medicine, Mayo Clinic, Rochester, MN 55902, USA., Perlstein EO; Perlara PBC, 2625 Alcatraz Ave #435, Berkeley, CA 94705, USA ethan@perlara.com. |
| Source: | Disease models & mechanisms [Dis Model Mech] 2019 Nov 11; Vol. 12 (11). Date of Electronic Publication: 2019 Nov 11. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Company of Biologists Ltd Country of Publication: England NLM ID: 101483332 Publication Model: Electronic Cited Medium: Internet ISSN: 1754-8411 (Electronic) Linking ISSN: 17548403 NLM ISO Abbreviation: Dis Model Mech Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31636082 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Iyer+S%22">Iyer S</searchLink>; Perlara PBC, 2625 Alcatraz Ave #435, Berkeley, CA 94705, USA.<br /><searchLink fieldCode="AU" term="%22Sam+FS%22">Sam FS</searchLink>; Perlara PBC, 2625 Alcatraz Ave #435, Berkeley, CA 94705, USA.<br /><searchLink fieldCode="AU" term="%22DiPrimio+N%22">DiPrimio N</searchLink>; Perlara PBC, 2625 Alcatraz Ave #435, Berkeley, CA 94705, USA.<br /><searchLink fieldCode="AU" term="%22Preston+G%22">Preston G</searchLink>; Department of Clinical Genomics and Department of Laboratory Medicine, Mayo Clinic, Rochester, MN 55902, USA.<br /><searchLink fieldCode="AU" term="%22Verheijen+J%22">Verheijen J</searchLink>; Department of Clinical Genomics and Department of Laboratory Medicine, Mayo Clinic, Rochester, MN 55902, USA.<br /><searchLink fieldCode="AU" term="%22Murthy+K%22">Murthy K</searchLink>; Perlara PBC, 2625 Alcatraz Ave #435, Berkeley, CA 94705, USA.<br /><searchLink fieldCode="AU" term="%22Parton+Z%22">Parton Z</searchLink>; Perlara PBC, 2625 Alcatraz Ave #435, Berkeley, CA 94705, USA.<br /><searchLink fieldCode="AU" term="%22Tsang+H%22">Tsang H</searchLink>; Perlara PBC, 2625 Alcatraz Ave #435, Berkeley, CA 94705, USA.<br /><searchLink fieldCode="AU" term="%22Lao+J%22">Lao J</searchLink>; Perlara PBC, 2625 Alcatraz Ave #435, Berkeley, CA 94705, USA.<br /><searchLink fieldCode="AU" term="%22Morava+E%22">Morava E</searchLink>; Department of Clinical Genomics and Department of Laboratory Medicine, Mayo Clinic, Rochester, MN 55902, USA.<br /><searchLink fieldCode="AU" term="%22Perlstein+EO%22">Perlstein EO</searchLink>; Perlara PBC, 2625 Alcatraz Ave #435, Berkeley, CA 94705, USA ethan@perlara.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101483332%22">Disease models & mechanisms</searchLink> [Dis Model Mech] 2019 Nov 11; Vol. 12 (11). <i>Date of Electronic Publication: </i>2019 Nov 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Company+of+Biologists+Ltd%22">Company of Biologists Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101483332 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1754-8411 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217548403%22">17548403 </searchLink><i>NLM ISO Abbreviation: </i>Dis Model Mech <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31636082 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1242/dmm.040584 Languages: – Code: eng Text: English Titles: – TitleFull: Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Iyer S – PersonEntity: Name: NameFull: Sam FS – PersonEntity: Name: NameFull: DiPrimio N – PersonEntity: Name: NameFull: Preston G – PersonEntity: Name: NameFull: Verheijen J – PersonEntity: Name: NameFull: Murthy K – PersonEntity: Name: NameFull: Parton Z – PersonEntity: Name: NameFull: Tsang H – PersonEntity: Name: NameFull: Lao J – PersonEntity: Name: NameFull: Morava E – PersonEntity: Name: NameFull: Perlstein EO IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 11 Text: 2019 Nov 11 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1754-8411 Numbering: – Type: volume Value: 12 – Type: issue Value: 11 Titles: – TitleFull: Disease models & mechanisms Type: main |
| ResultId | 1 |
